Recent evidence also appears to implicate PLEXIND1 in pathologic TGFβ signaling, which acts as a co-receptor to promote tumor growth and reduce E-cadherin expressing in tumor cells with oncogenic KRAS mutation. The gene discussed is TGFB1; the disease is neoplasm.